# CVS Health Corporation (CVS)

**Exchange:** NYSE  
**Sector:** Healthcare  
**Market cap:** $124.58B  
**Price:** $98.02 (+0.99%)

> CVS Health Corporation is a leading health solutions company that provides comprehensive healthcare services across multiple segments. It operates through Health Care Benefits, offering health insurance and benefits to millions; Health Services, which includes pharmacy benefit management solutions, medical clinics, virtual care, and in-home services; and Pharmacy and Consumer Wellness, encompassing retail pharmacies and consumer health products. These segments enable CVS Health Corporation to deliver integrated care, from prescription management and drug dispensing to primary care and wellness offerings. The company serves individuals, employers, health plans, and government programs, playing a pivotal role in the U.S. healthcare ecosystem by bridging retail pharmacy, insurance, and clinical services. Founded in 1963 and headquartered in Woonsocket, Rhode Island, CVS Health Corporation stands as a key player in retail trade and healthcare services, focusing on accessible and coordinated health solutions in today's market.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $402.07B | $180.90B | $4.66B | $1.77B | $1.39 |
| 2024 | $372.81B | $166.52B | $8.52B | $4.61B | $3.66 |
| 2023 | $357.78B | $140.68B | $13.74B | $8.34B | $6.47 |
| 2022 | $322.47B | $125.58B | $7.95B | $4.31B | $3.26 |
| 2021 | $292.11B | $116.31B | $13.31B | $8.00B | $6.02 |
| 2020 | $268.71B | $104.72B | $13.91B | $7.18B | $5.46 |
| 2019 | $256.78B | $98.06B | $11.99B | $6.63B | $5.08 |
| 2018 | $193.92B | $37.47B | $4.02B | -$594M | $-0.57 |
| 2017 | $184.76B | $28.55B | $9.54B | $6.62B | $6.44 |
| 2016 | $177.53B | $28.86B | $10.39B | $5.32B | $4.90 |
| 2015 | $153.29B | $26.53B | $9.47B | $5.24B | $4.63 |
| 2014 | $139.37B | $25.37B | $8.80B | $4.64B | $3.96 |
| 2013 | $126.76B | $23.78B | $8.04B | — | $3.74 |
| 2012 | $123.12B | $22.49B | $7.21B | — | $3.02 |
| 2011 | $107.08B | $20.56B | $6.33B | — | $2.57 |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2025 | $253.54B | $178.16B | $75.21B | $8.45B | — |
| 2024 | $253.22B | $177.49B | $75.56B | $8.59B | — |
| 2023 | $249.73B | $173.09B | $76.46B | $8.20B | — |
| 2022 | $228.28B | $156.51B | $71.47B | $12.95B | — |
| 2021 | $233.00B | $157.62B | $75.08B | $9.41B | — |
| 2020 | $230.72B | $161.01B | $69.39B | $7.85B | — |
| 2019 | $222.45B | $158.28B | $63.86B | $5.68B | $64.70B |
| 2018 | $196.46B | $137.91B | $58.23B | $4.06B | $73.43B |
| 2017 | $95.13B | $57.44B | $37.69B | $1.70B | $27.00B |
| 2016 | $94.46B | $57.63B | $36.83B | $3.37B | $25.70B |
| 2015 | $92.44B | $55.24B | $37.20B | $2.46B | $27.50B |
| 2014 | $74.19B | $36.23B | $37.96B | $2.48B | $12.30B |
| 2013 | $71.53B | $33.59B | $37.94B | $4.09B | $13.40B |
| 2012 | $66.22B | $28.57B | $37.65B | $1.38B | $9.10B |
| 2011 | $64.85B | $26.84B | $38.01B | $1.41B | $9.30B |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | $10.64B | $2.83B | $7.81B |
| 2024 | $9.11B | $2.78B | $6.33B |
| 2023 | $13.43B | $3.03B | $10.39B |
| 2022 | $16.18B | $2.73B | $13.45B |
| 2021 | $18.27B | $2.52B | $15.74B |
| 2020 | $15.87B | $2.44B | $13.43B |
| 2019 | $12.85B | $2.46B | $10.39B |
| 2018 | $8.87B | $2.04B | $6.83B |
| 2017 | $8.01B | $1.92B | $6.09B |
| 2016 | $10.14B | $2.22B | $7.92B |
| 2015 | $8.54B | $2.37B | $6.17B |
| 2014 | $8.14B | $2.14B | $6.00B |
| 2013 | $5.78B | $1.98B | $3.80B |
| 2012 | $6.67B | $2.03B | $4.64B |
| 2011 | $5.86B | $1.87B | $3.98B |

Source: [CompaniesByCap](https://companiesbycap.com/company/CVS)